Business and Corporate Law

• Corporate Law
  Ms. O’Farrell also serves as a member of the board of directors of Inhibikase Therapeutics since December 2020 and LENSAR, Inc. since January 2021. In December 2017, Ms. O’Farrell retired from a 24-year career with Eli Lilly and Company where she held several senior management positions in finance and corporate governance, most recently serving as Chief Procurement Officer and Head of Global Shared Services from January 2012 to December 2017.